1. Home
  2. DGLY vs NLSP Comparison

DGLY vs NLSP Comparison

Compare DGLY & NLSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DGLY
  • NLSP
  • Stock Information
  • Founded
  • DGLY N/A
  • NLSP 2015
  • Country
  • DGLY United States
  • NLSP Switzerland
  • Employees
  • DGLY N/A
  • NLSP N/A
  • Industry
  • DGLY Radio And Television Broadcasting And Communications Equipment
  • NLSP Biotechnology: Pharmaceutical Preparations
  • Sector
  • DGLY Technology
  • NLSP Health Care
  • Exchange
  • DGLY Nasdaq
  • NLSP Nasdaq
  • Market Cap
  • DGLY 8.4M
  • NLSP 8.2M
  • IPO Year
  • DGLY N/A
  • NLSP 2021
  • Fundamental
  • Price
  • DGLY $2.38
  • NLSP $0.22
  • Analyst Decision
  • DGLY
  • NLSP Hold
  • Analyst Count
  • DGLY 0
  • NLSP 1
  • Target Price
  • DGLY N/A
  • NLSP N/A
  • AVG Volume (30 Days)
  • DGLY 23.8K
  • NLSP 29.3M
  • Earning Date
  • DGLY 08-12-2024
  • NLSP 07-30-2024
  • Dividend Yield
  • DGLY N/A
  • NLSP N/A
  • EPS Growth
  • DGLY N/A
  • NLSP N/A
  • EPS
  • DGLY N/A
  • NLSP N/A
  • Revenue
  • DGLY $26,080,507.00
  • NLSP N/A
  • Revenue This Year
  • DGLY $22.14
  • NLSP N/A
  • Revenue Next Year
  • DGLY N/A
  • NLSP N/A
  • P/E Ratio
  • DGLY N/A
  • NLSP N/A
  • Revenue Growth
  • DGLY N/A
  • NLSP N/A
  • 52 Week Low
  • DGLY $1.73
  • NLSP $0.11
  • 52 Week High
  • DGLY $4.40
  • NLSP $1.21
  • Technical
  • Relative Strength Index (RSI)
  • DGLY 47.59
  • NLSP 55.08
  • Support Level
  • DGLY $2.04
  • NLSP $0.19
  • Resistance Level
  • DGLY $2.65
  • NLSP $0.22
  • Average True Range (ATR)
  • DGLY 0.16
  • NLSP 0.03
  • MACD
  • DGLY 0.03
  • NLSP -0.00
  • Stochastic Oscillator
  • DGLY 54.55
  • NLSP 13.68

About DGLY Digital Ally Inc.

Digital Ally Inc produces digital video imaging and storage products for use in law enforcement, security, and commercial applications. Its products are an in-car digital video/audio recorder contained in a rear-view mirror for use in law enforcement and commercial fleets. It can integrate electronic, radio, computer, and multi-media technologies to create solutions to address needs in a variety of other industries and markets, including mass transit, school buses, taxicab, and military. The company sells its products directly to law enforcement agencies, security organizations, and consumer and commercial fleet operators both domestically and internationally through third-party distributors. Its segments include Video Solutions, Revenue Cycle Management, and Entertainment.

About NLSP NLS Pharmaceutics Ltd.

NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.

Share on Social Networks: